Startups
HekaBio is a unique Japan-based healthcare development, investment and commercialization platform, with broad experience including oncology radiation and cardiovascular therapies.
We invest in leading global innovations in oncology, radiation and cardiovascular therapy, and successfully accelerate commercialization.
Our mission is to bring significant benefit to patients suffering from intractable diseases.
We invest in leading global innovations in oncology, radiation and cardiovascular therapy, and successfully accelerate commercialization.
Our mission is to bring significant benefit to patients suffering from intractable diseases.
Overview
Location
Japan, Chuo
Employees
11-50
Founded date
2016
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 8, 2024 | Serpin Pharma and HekaBio Sign Term Sheet for Groundbreaking Neuropathy Treatment | Serpin Pharma and HekaBio have signed a term sheet to develop and commercialize SP163M for preventing chemotherapy-induced peripheral neuropathy (CIPN). MANASSAS, VIRGINIA, UNITED STATES, July 8, 2024 /EINPresswire.com/ -- Serpin Pharma, a ... |
| Jun 19, 2024 | HekaBio Co., Ltd. Terrapeutics Pharma and HekaBio K.K. collaborate to bring innovative drug discovery platform to Japan | |
| Jun 19, 2024 | HekaBio Co., Ltd. Terrapeutics Pharma and HekaBio K.K. collaborate to bring innovative drug discovery platform to Japan | Heka Bio Co., Ltd. Terrapeutics Pharma and HekaBio K.K. partner to bring innovative drug discovery platform to Japan …… [Reference materials] This press release is a Japanese translation of the English version of the press release issued on... |
| Jun 27, 2023 | Vertex Ventures Healthcare Announces USD 200 Million Fund III to Promote Healthcare Innovation | BOSTON & SAN FRANCISCO –The USD 200 million third and largest fund of Vertex Ventures HC (VVHC), a women-led global healthcare investment organization, has just begun operations. Fund III will assist and empower ground-breaking life sci... |
Reviews 0
FAQ about HekaBio K.K.
When was HekaBio K.K. founded?
HekaBio K.K. was founded in 2016.
What has the press written about HekaBio K.K.?
Parsers VC has collected 5 articles mentioning HekaBio K.K., among them “Serpin Pharma and HekaBio Sign Term Sheet for Groundbreaking Neuropathy Treatment” (Jul 8, 2024) and “HekaBio Co., Ltd. Terrapeutics Pharma and HekaBio K.K. collaborate to bring innovative drug discovery platform to Japan” (Jun 19, 2024).
Is HekaBio K.K. still active?
Yes, HekaBio K.K. is active; its latest activity on Parsers VC dates from Oct 1, 2025.